Page 11 - அட்லஸ் துணிகர News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அட்லஸ் துணிகர. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அட்லஸ் துணிகர Today - Breaking & Trending Today

Gene therapy funding frenzy reaches Affinia as it reels in $110M in new capital

Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy. ....

United States , United Kingdom , Luk Vandenberghe , Vertex Pharmaceuticals , Grousbeck Gene Therapy Center At Massachusetts Eye , American Society Of Gene , Enterprise Associates , Atlas Venture , Harvard Medical School , American Society , Cell Therapy , Grousbeck Gene Therapy Center , Massachusetts Eye , Harvard Medical , Thousand Oaks , California Based Capsida , Dyno Therapeutics , Sarepta Therapeutics , Farallon Capital , Avidity Partners , Casdin Capital , Octagon Capital , Perceptive Advisors , Woodline Partners , F Prime Capital , Mass General Brigham Ventures ,

Pharma Industry M&a Scrutiny in Sen. Amy Klobuchar's Book

Pharma Industry M&a Scrutiny in Sen. Amy Klobuchar's Book
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Nova Scotia , Leerink Geoffrey Porges , Amy Klobuchar , Novation Pharmaceuticals , Atlas Venture , Federal Trade Commission , Wall Street , Geoffrey Porges , Minnesota Democrat , Harvard Business Review , Bruce Booth , Merger Enforcement Improvement Act , State Street , Big Pharma , ஒன்றுபட்டது மாநிலங்களில் , கருப்பு பாறை , நோவா ஸ்கோடியா , ஆமி கிலொபூச்சர் , ஓவேஶந் மருந்துகள் , அட்லஸ் துணிகர , கூட்டாட்சியின் வர்த்தகம் தரகு , சுவர் தெரு , ஜெஃப்ரி போற்கேஸ் , மினசோட்டா ஜனநாயகவாதி , ஹார்வர்ட் வணிக விமர்சனம் ,

Affinivax Appoints Stuart Chaffee, PhD, as Chief Business Officer

Press release content from Business Wire. The AP news staff was not involved in its creation.
Affinivax Appoints Stuart Chaffee, PhD, as Chief Business Officer
April 20, 2021 GMT
Affinivax Chief Business Officer Stuart Chaffee PhD (Photo: Business Wire)
CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 20, 2021
Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform, today announced that Stuart Chaffee, PhD, has joined the company as Chief Business Officer. Dr. Chaffee brings to Affinivax extensive experience in business operations, finance and corporate development, including previous roles as Chief Business Officer and CFO at Praxis Precision Medicines and as Head of Business Operations and Co-founder of Kymera Therapeutics. ....

United States , United Kingdom , Steven Brugger , Stuart Chaffee , Kathryn Morris , Yale University , College Of William , Program Leadership , Melinda Gates Foundation , Affinivax Inc , Yates Network , Wharton School Of The University Pennsylvania , Business Development , Multiple Antigen Presenting System , Chief Business , Chief Business Officer , Praxis Precision Medicines , Business Operations , Chief Business Officer Stuart Chaffee Phd , Business Wire , Chief Executive Officer , Chief Financial Officer , Praxis Precision , Atlas Venture , Wharton School , Boston Children ,

Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer

Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer
April 15, 2021 02:00 ET
| Source:
Sitryx Therapeutics
Sitryx Therapeutics
LONDON, UNITED KINGDOM
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer
Oxford, UK – 15 April 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation, today announces the appointment of Iain Kilty, Ph.D., as its Chief Scientific Officer.
Iain will lead the development and execution of the Company’s research strategy and advancement of the Company’s pipeline of disease-modifying therapeutics in immuno-oncology and immuno-inflammation. ....

United Kingdom , David Daley , Melissa Gardiner , Mary Jane Elliott , Iain Kilty , Preclinical Sciences , Breast Cancer Research Laboratories , Immunology Research Unit At Pfizer , Jesus College , University Of Liverpool , United Kingdom Government Research Excellence Framework , University Of Cambridge , Sitryx The Company , Consilium Strategic Communications , Chief Scientific , Chief Executive Officer , Quench Bio , Chief Scientific Officer , Vice President Preclinical Sciences , Immunology Research Unit , Atlas Venture , United Kingdom Government , Research Excellence Framework , Jane Elliott , Sitryx Therapeutics , Sitryx Therapeutics ,

These are the 17 Largest NYC Tech Startup Funding Rounds of Q1 2021

These are the 17 Largest NYC Tech Startup Funding Rounds of Q1 2021
alleywatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alleywatch.com Daily Mail and Mail on Sunday newspapers.

New York , United States , River Wood , New Zealand General , New Zealand , Brandon Krieg , Jan Moller , Saman Rahmanian , Theodore Bailey , Johnny Ayers , Rob Schutz , Kleiner Perkins , Daniel Brillman , Dan Cogan , Anthony Casalena , Marius Tirca , Benjamin Darnell , Max Yankelevich , Michael Gronager , Lerer Hippeau , Andreessen Horowitz , Kareem Elsirafy , Zachariah Reitano , Kayne Anderson Rudnick , Adam Singolda , Sam Hendel ,